| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,858 |
3,591 |
$227K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,838 |
1,295 |
$51K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
428 |
428 |
$35K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
399 |
399 |
$33K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
346 |
333 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
397 |
388 |
$20K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,048 |
2,044 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
197 |
197 |
$17K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
196 |
192 |
$16K |
| 90461 |
|
319 |
318 |
$11K |
| 96127 |
|
961 |
961 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
402 |
402 |
$8K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
280 |
272 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
169 |
165 |
$6K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
583 |
583 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
60 |
58 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
216 |
212 |
$3K |
| 99177 |
|
181 |
181 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
169 |
166 |
$2K |
| 0071A |
|
43 |
43 |
$2K |
| 0072A |
|
31 |
31 |
$1K |
| 83655 |
|
101 |
101 |
$1K |
| 85018 |
|
427 |
427 |
$1K |
| 81002 |
|
301 |
294 |
$791.91 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
21 |
21 |
$649.95 |
| 0001A |
|
12 |
12 |
$550.56 |
| 36416 |
|
28 |
28 |
$266.00 |